These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 22288557)

  • 21. Hypoxia-Dependent HIF-1 Activation Impacts on Tissue Remodeling in Graves' Ophthalmopathy-Implications for Smoking.
    Görtz GE; Horstmann M; Aniol B; Reyes BD; Fandrey J; Eckstein A; Berchner-Pfannschmidt U
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4834-4842. PubMed ID: 27610652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Graves' orbitopathy and oxidative stress.
    Novembrino C; De Giuseppe R; Bamonti F; Pigatto PD; Guzzi G
    Orbit; 2011 Mar; 30(2):63. PubMed ID: 20919814
    [No Abstract]   [Full Text] [Related]  

  • 23. Evidence for enhanced Thy-1 (CD90) expression in orbital fibroblasts of patients with Graves' ophthalmopathy.
    Khoo TK; Coenen MJ; Schiefer AR; Kumar S; Bahn RS
    Thyroid; 2008 Dec; 18(12):1291-6. PubMed ID: 18976167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Graves' disease and Graves' ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene.
    Zhang Q; Yang YM; Lv XY
    J Zhejiang Univ Sci B; 2006 Nov; 7(11):887-91. PubMed ID: 17048303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD4+ T cells and the Th1/Th2 imbalance are implicated in the pathogenesis of Graves' ophthalmopathy.
    Xia N; Zhou S; Liang Y; Xiao C; Shen H; Pan H; Deng H; Wang N; Li QQ
    Int J Mol Med; 2006 May; 17(5):911-6. PubMed ID: 16596280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of tanshinone IIA in an in vitro model of Graves' orbitopathy.
    Rhiu S; Chae MK; Lee EJ; Lee JB; Yoon JS
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):5900-10. PubMed ID: 25159204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smoking induces overexpression of immediate early genes in active Graves' ophthalmopathy.
    Planck T; Shahida B; Parikh H; Ström K; Åsman P; Brorson H; Hallengren B; Lantz M
    Thyroid; 2014 Oct; 24(10):1524-32. PubMed ID: 25135760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidative stress and antioxidant activity in orbital fibroadipose tissue in Graves' ophthalmopathy.
    Hondur A; Konuk O; Dincel AS; Bilgihan A; Unal M; Hasanreisoglu B
    Curr Eye Res; 2008 May; 33(5):421-7. PubMed ID: 18568878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type 2 deiodinase and brown fat: the heat is on--or off.
    Fliers E; Boelen A
    Endocrinology; 2010 Sep; 151(9):4087-9. PubMed ID: 20736402
    [No Abstract]   [Full Text] [Related]  

  • 30. Evaluation of the National Eye Institute visual function questionnaire in Graves' ophthalmopathy.
    Bradley EA; Sloan JA; Novotny PJ; Garrity JA; Woog JJ; West SK
    Ophthalmology; 2006 Aug; 113(8):1450-4. PubMed ID: 16769116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of CTLA-4 gene polymorphism with Graves' disease and ophthalmopathy in Iranian patients.
    Esteghamati A; Khalilzadeh O; Mobarra Z; Anvari M; Tahvildari M; Amiri HM; Rashidi A; Solgi G; Parivar K; Nikbin B; Amirzargar A
    Eur J Intern Med; 2009 Jul; 20(4):424-8. PubMed ID: 19524188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of thyrotropin and thyrotropin-receptor-stimulating Graves' disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves' ophthalmopathy patients.
    van Zeijl CJ; Fliers E; van Koppen CJ; Surovtseva OV; de Gooyer ME; Mourits MP; Wiersinga WM; Miltenburg AM; Boelen A
    Thyroid; 2010 May; 20(5):535-44. PubMed ID: 20384487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible targets for nonimmunosuppressive therapy of Graves' orbitopathy.
    Zhang L; Grennan-Jones F; Draman MS; Lane C; Morris D; Dayan CM; Tee AR; Ludgate M
    J Clin Endocrinol Metab; 2014 Jul; 99(7):E1183-90. PubMed ID: 24758182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pax-8 expression correlates with type II 5' deiodinase expression in thyroids from patients with Graves' disease.
    Ambroziak M; Pachucki J; Chojnowski K; Wiechno W; Nauman J; Nauman A
    Thyroid; 2003 Feb; 13(2):141-8. PubMed ID: 12699588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Latanoprost is effective in reducing high intraocular pressure associated with Graves' ophthalmopathy.
    Gumińska M; Kłysik A; Siejka A; Jurowski P
    Klin Oczna; 2014; 116(2):89-93. PubMed ID: 25345284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parameters predicting outcomes of strabismus surgery in the management of Graves' ophthalmopathy.
    Nassar MM; Dickinson AJ; Neoh C; Powell C; Buck D; Galal E; Clarke MP
    J AAPOS; 2009 Jun; 13(3):236-40. PubMed ID: 19395292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutting edge: retrobulbar inflammation, adipogenesis, and acute orbital congestion in a preclinical female mouse model of Graves' orbitopathy induced by thyrotropin receptor plasmid-in vivo electroporation.
    Moshkelgosha S; So PW; Deasy N; Diaz-Cano S; Banga JP
    Endocrinology; 2013 Sep; 154(9):3008-15. PubMed ID: 23900776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative measurements for type 1 deiodinase messenger ribonucleic acid in human peripheral blood mononuclear cells: mechanism of the preferential increase of T3 in hyperthyroid Graves' disease.
    Nishikawa M; Toyoda N; Yonemoto T; Ogawa Y; Tabata S; Sakaguchi N; Tokoro T; Gondou A; Yoshimura M; Yoshikawa N; Inada M
    Biochem Biophys Res Commun; 1998 Sep; 250(3):642-6. PubMed ID: 9784399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Euthyroid Graves' ophthalmopathy with negative autoantibodies.
    Cakir M
    J Natl Med Assoc; 2005 Nov; 97(11):1547-9. PubMed ID: 16334503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenic Phenotype of Adipogenesis and Hyaluronan in Orbital Fibroblasts From Female Graves' Orbitopathy Mouse Model.
    Görtz GE; Moshkelgosha S; Jesenek C; Edelmann B; Horstmann M; Banga JP; Eckstein A; Berchner-Pfannschmidt U
    Endocrinology; 2016 Oct; 157(10):3771-3778. PubMed ID: 27552248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.